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Nanosize surface of sodium montmorillonite has been 
prepared via sonication and deposited on glassy carbon electrodes 
for use as working electrode in a highly sensitive electrochemical 
biosensor for the detection of trace amounts of the calcium 
channel blocking drug, amlodipine. The cyclic voltammetric 
behaviour of amlodipine is studied in the pH range of 1.0−13.0. In 
alkali medium (pH 13.0) the sensor shows good response. Cyclic 
voltammograms show one oxidation peak and one broad reduction 
peak, which may be due to the oxidation of secondary amino 
group and reduction of chlorine and nitro groups respectively. 
Plots of log peak current and potential when correlated with  
log scan rate, indicate irreversible electron diffusion controlled 
redox reaction. The optimum conditions have been established by 
differential pulse stripping voltammetry. The anodic peak current 
is linear with concentration of the analyte at optimum conditions; 
the detection limit has been determined to be 0.01 µg/mL. 
A simple, sensitive and time-saving differential pulse stripping 
voltammetric procedure has been developed for estimation of 
amlodipine in its formulations as tablets. 
Keywords: Electroanalytical chemistry, Electrochemistry, Sensors, 
Clays, Sodium montmorillonite, Cyclic voltammetry, 
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For several decades now, the utilization of sodium 
montmorillonite (NaMM) has been popular in 
electrochemical studies. NaMM is smectite clay with 
high chemical stability, good adsorption and good 
penetrability, thus making it suitable as effective  
clay modified glassy carbon electrode for 
electrochemical studies. Electrochemical behavior of 
small redox substances incorporated into the clay 
modified membrane has been studied extensively
1
. 
Montmorillonite modified electrodes have been 




Calcium, an essential chemical in the process  
of muscle contraction, is directly involved in  
the electrochemical reactions that allow muscle  
cells to contract as part of a regular heartbeat. 
Calcium is vital for maintaining good health, as  
it is involved in many every day cellular processes, 
including gene regulation, memory and cell  
death. However, excessive levels of calcium can  
lead to arrhythmias, as well as hypertrophy,  
apoptosis and cardiac remodeling. By virtue of  
their ability to increase nitric oxide (NO) production, 
it is believed that calcium channel blockers  
(CCBs) may be involved in the inhibition of  
platelet aggregation
6
. Amlodipine besylate is a 
dihydropyridine derivative with calcium antagonist 
activity
7
. It is used mainly as an anti-hypertensive  
and anti-anginal agent. The main metabolic pathway 
is by the oxidation of dihydropyridine ring to  
its pyridine analog
8







 have been applied 
for estimation of amlodipine besylate in tablets  
and biological fluids. Amlodipine besylate has  
also been determined by spectrophotometric 
methods
12
. Chromatographic methods offer a high 
degree of selectivity but need sample clean-up and 
relatively heavy instrumentation. A differential pulse 
stripping voltammetric method
13
 has been described 
for the determination of amlodipine besylate at  
pH 5.5. The polarographic and voltammetric behavior 
of some calcium antagonist drugs at the dropping 




Thus, the determination of calcium channel blocker 
such as amlodipine, with enhanced sensitivity and 
utilization of natural materials assumes significance. 
The present study is aimed at the electrochemical 
behavior and assay of amlodipine at a NaMM clay 
modified glassy carbon electrode. 
 
Experimental 
Electroanalytical studies were carried out on a  
CH Instruments electrochemical workstation  
(model 760C). The calcium channel blocker  
drug, amlodipine, was received from Sri 
International Pharmaceuticals, Mumbai, India 
and used as such. 




The stock solutions were made up in 
methanol/doubly distilled TKA-LAB purified water 
(80:20). In aqueous (80:20) methanol media of 
Britton Robinson buffer tablet (4.0, 7.0, 9.2), KCl 
and H2SO4 (0.1 mol dm
-3
) were used as 
supporting electrolyte for the analysis. 
Montmorillonite KSF was purchased from Acros 
Organics, Belgium. 
Purging and blanketing of nitrogen were carried 
out for the analyte solution placed in the 
electrochemical cell of 15 mL capacity for 25 min 
under stirring prior to recording the voltammograms. 
In order to get reproducible results, the glassy carbon 
electrode was pretreated in two ways: (a) mechanical 
polishing over a velvet micro-cloth with an alumina 
suspension, and, (b) electrochemical treatment by 
applying a potential of 1.5 V for 2 s. 
For preparation of the sodium montmorillonite 
modified glassy carbon electrode, the montmorillonite 
clay (5 g) was washed with Ultrapure water and dried 
at ambient temperature. Mixtures of the washed 
montmorillonite KSF clay samples (1 g) and sodium 
chloride (5 mL, 0.5 M) were ultrasonicated for 4 h 
and then kept for 1 h. The clay was centrifuged, 
washed thoroughly with water and dialyzed to remove 
the salt before being dried. Ultrasonication of about 
0.1 g of sodium montmorillonite in 10 mL water and 
100 mg of carboxy methylcellulose (CMC) was done 
for 1 h.  Sodium montmorillonite colloid (SMC) was 
prepared from the purified montmorillonite powder as 
described previously
5
. An aliquot of SMC (120 µL) 
was mixed with 100 mg of carboxy methylcellulose 
(CMC) and then the mixture was diluted with 
deionized water to obtain a pretreated sodium 
montmorillonite colloid (PSMC). Aliquots  of PSMC 
(5 µL) were deposited onto glassy carbon electrodes 
(GCE, 3 mm dia.) and allowed to dry under ambient 
conditions to form a montmorillonite layer on the 
electrode surface. The resulting clay-modified 
electrode which was used as the working electrode, 
showed no peak in cyclic voltammetry. The 
montmorillonite modified electrode was kept in the 
electrolyte solution for 5 days and thereafter, a CV 
was taken. There was only 4.2% decrease in the 
background current. After 5 days, the montmorillonite 
deposits partially peeled off from the glassy carbon 
electrode surface.  The continuous potential cycling of 
the adsorbed montmorillonite for 48 h resulted in only 
5% decrease in the current. Distilled water was used 
to carefully remove and clean the coating, followed 
by surface treatment to clean the glassy carbon 
electrode after each experiment. Nitric acid (6 M) 
solution was used to clean the cell. 
 
Results and discussion 
The voltammetric behavior of amlodipine calcium 
channel blocker drug was examined in the pH range 
1.0–13.0 by recording their cyclic voltammograms. 
The effect of the pH on the peak current and potential 
is presented in Fig. 1(a & b). The dependence of pH 
on peak current results in a maximum at pH 13.0. 
Since the best shape and sensitivity of the peak 
current was obtained at pH 13.0 for the drug, this pH 
value is considered most suitable for the stripping 
voltammetric analysis. Figure 2 shows the 
 
 
Fig. 1 − Effect of pH on (a) potential and (b) peak current, in the 










representative cyclic voltammogram of 100 µg/mL of 
the drug at pH 13.0. In acid medium, one well defined 
peak around 0.5 V was observed, while another one 
peak with poor characteristics was also observed at 
more negative potential. These two peaks may be due 
to oxidation of the secondary NH group and reduction 
of chlorine/nitro groups respectively. The negative 
shift of the peak potential towards more negative 
values with increasing pH indicates that the 
protonation step precedes the electron transfer. The 
nature of the oxidation process was studied by 
following the effect of the scan rate on the peak 
current. Both ip versus ν
1/2
 and log ip versus log ν 
plots were linear, indicating a diffusion-controlled 
process (Fig. 3(a & b)). Peak potential of both peaks 
shifts towards more negative values with the increase 
of the pH. The irreversibility of oxidation of the drug 
at NaMM/GCE was ascertained from the larger 
difference in anodic and cathodic peak potentials at 
all pHs in the range of 1.0−13.0. 
Cyclic voltammetric results reveal good 
electroactivity of the substrate on the electrode at  
pH 13.0. Differential pulse mode was employed for 
stripping voltammetric studies and good performance 
was seen in the determination of the drug on clay 
modified glassy carbon electrode. Experiments were 
carried to find out the best accumulation potential at 
the chosen pH 13.0 with solution containing  
0.1 µg/mL of the drug. The accumulation potential 
(Eacc) was varied from −05 to 0.6 V at deposition time 
of 15 s. The maximum peak current was observed for  
an accumulation potential at -0.1 V for amlodipine 
(Fig. 4). This may be due to electrostatic attraction 
between the protonated substrate and negatively 
charged working electrode. Deposition time was 
varied from 15 s to 90 s and the differential pulse 
voltammogram was recorded. The maximum current 
response was observed at 15 s for amlodipine. The 
initial scan potential (ip) is also an important 
parameter like accumulation potential. The initial scan 
potential was varied between −0.5 and 0.3V for  drug 
and the maximum stripping peak current was 
observed at −0.2 amlodipine. 
The accumulation of the antihypertensive drug, 
amlodipine, on the modified electrode surface under 
the optimum accumulation conditions was identify 
from the changes in the electrode surface before and 
after accumulation. SEM was employed to study the 
surface morphology of the accumulated drug on 
NaMM coated glassy carbon electrode. The SEM 
image of NaMM shows small uniform granular surface 
as previously reported
15-18
. The drug amlodipine was 
adsorbed on NaMM electrode during accumulation and 
exhibited large flake-like structure (Fig. 5). Due to the 
better accumulation, stripping leads to good results and 
hence stripping parameters was optimized. 
The factors affecting the stripping step, i.e., 
primary oxidation process, were varied and optimum 
conditions were arrived at. The influences of pulse 
height, pulse width and potential scan increment were 
studied by varying their values and the maximum 
peak current conditions were obtained. The range of 
study and optimized conditions are presented in  
 
 
Fig. 3 – (a) Plot of peak current versus scan rate, and, (b) plot of 
log peak current versus log scan rate. 
 
 
Fig. 4 − Plot of peak current versus accumulation potential. 




Table 1. The optimum conditions that resulted in 
maximum peak current response were used to study 
the effect of analyte concentration. 
Since differential pulse stripping voltammetry 
(DPSV) is a technique with a better peak shape and 
higher sensitivity, DPSV was employed for the 
determination of the drug. Figure 6 shows the DPSV 
curves of the drug, amlodipine, under optimum 
conditions. The experimental results showed that the 
peak current increased with the increase in 
concentration of drugs. In the range studied from 
0.03−0.35 µg/mL for amlodipine, the anodic peak 
current is linearly proportional to the concentration 
of the drug. The calibration plot indicates the linear 
dependence of peak current with concentration under 
optimum experimental conditions. The limit of 
detection was found to be 0.01µg/mL for 
amlodipine. The reproducibility of the stripping 
signal  was  realized  in  terms  of  relative  standard  
Table 1 − Optimum experimental conditions in DPSV studies 
 
Variable Range studied Optimum value 
pH 1-13 13.0 
Accumulation potential (V) 0–0.6 0.3 
Accumulation time (s) 15–90 15 
Initial scan potential (V) -0.2 to 0.3 0.1 
Pulse height (PH) (mV) 25–150 50 
Pulse width (PW) (ms) 25–150 50 
Scan increment (SI) mV 2–20 4 
Stirring rate (rpm) 50–250 250 
Rest period (s) 2–10 5 
Table 2 − Estimation of amlodipine by DPSV with the 
proposed electrode 
Sample Amlodipine (mg) % RSD 
Cert. Expt. 
Amace (Systopic) 5 4.90 2.4 
Amlodac (Zydus Medica) 10 9.86 2.5 
Amlopres (Cipla) 10 9.75 2.3 
Myodura (Wockhardt) 10 9.92 2.2 
Lama (Stadmed) 10 9.85 2.8 
Card (Jagsonpal) 10 9.91 2.1 
Calchek (Ipca) 10 9.95 2.0 
 
deviation for seven readings at a concentration level 
of 0.05 µg/mL. 
The pharmaceutical formulations of amlodipine in 
the form of tablets from various pharmaceutical 
companies were analyzed. Stripping voltammograms 
of the drug at pH 13.0 were recorded under optimum 
conditions. The concentration of the calcium channel 
blocker in commercial formulations determined by 
the proposed method was in good agreement with the 
value certified by the manufacturer (Table 2). 
In the present study, the electrochemical oxidation 
of calcium channel blocker drug at a sodium 
montmorillonite modified GCE was studied in different 
buffer solutions and a validated voltammetric 
procedure described for its determination. The 
proposed procedure provides a sensitive and simple 
approach to the determination of drugs in 
pharmaceutical formulations. The accuracy, 
reproducibility, simplicity and selectivity suggest its 
application in quality control analysis, clinical 
laboratories and pharmacokinetic studies. 
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